Annual long term debt:
$1.66B+$932.50M(+128.67%)Summary
- As of today (May 21, 2025), VRTX annual long term debt is $1.66 billion, with the most recent change of +$932.50 million (+128.67%) on December 31, 2024.
- During the last 3 years, VRTX annual long term debt has risen by +$770.00 million (+86.79%).
- VRTX annual long term debt is now at all-time high.
Performance
VRTX Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$1.65B-$8.10M(-0.49%)Summary
- As of today (May 21, 2025), VRTX quarterly long term debt is $1.65 billion, with the most recent change of -$8.10 million (-0.49%) on March 31, 2025.
- Over the past year, VRTX quarterly long term debt has increased by +$927.80 million (+128.63%).
- VRTX quarterly long term debt is now -3.16% below its all-time high of $1.70 billion, reached on September 30, 2024.
Performance
VRTX Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
VRTX Long term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +128.7% | +128.6% |
| 3 y3 years | +86.8% | +89.0% |
| 5 y5 years | +166.1% | +209.4% |
VRTX Long term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +128.7% | -3.2% | +128.6% |
| 5 y | 5-year | at high | +166.1% | -3.2% | +215.9% |
| alltime | all time | at high | >+9999.0% | -3.2% | >+9999.0% |
VRTX Long term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.65B(-0.5%) |
| Dec 2024 | $1.66B(+128.7%) | $1.66B(-2.7%) |
| Sep 2024 | - | $1.70B(+82.4%) |
| Jun 2024 | - | $933.40M(+29.4%) |
| Mar 2024 | - | $721.30M(-0.5%) |
| Dec 2023 | $724.70M(-10.6%) | $724.70M(-2.7%) |
| Sep 2023 | - | $744.70M(-3.0%) |
| Jun 2023 | - | $767.60M(-2.7%) |
| Mar 2023 | - | $789.20M(-2.6%) |
| Dec 2022 | $810.30M(-8.7%) | $810.30M(-1.7%) |
| Sep 2022 | - | $824.60M(-2.7%) |
| Jun 2022 | - | $847.30M(-2.9%) |
| Mar 2022 | - | $872.50M(-1.7%) |
| Dec 2021 | $887.20M(-0.3%) | $887.20M(+1.2%) |
| Sep 2021 | - | $876.80M(-1.9%) |
| Jun 2021 | - | $893.85M(-0.6%) |
| Mar 2021 | - | $898.80M(+1.0%) |
| Dec 2020 | $889.50M(+42.8%) | $889.50M(+62.8%) |
| Sep 2020 | - | $546.51M(+4.7%) |
| Jun 2020 | - | $522.07M(-2.0%) |
| Mar 2020 | - | $532.95M(-14.4%) |
| Dec 2019 | $622.87M(+7.1%) | $622.87M(+3.0%) |
| Sep 2019 | - | $604.54M(-1.2%) |
| Jun 2019 | - | $611.96M(-1.9%) |
| Mar 2019 | - | $623.87M(+7.3%) |
| Dec 2018 | $581.55M(-0.4%) | $581.55M(+0.9%) |
| Sep 2018 | - | $576.53M(-0.2%) |
| Jun 2018 | - | $577.67M(-0.1%) |
| Mar 2018 | - | $578.21M(-1.0%) |
| Dec 2017 | $583.90M(+12.0%) | $583.90M(+2.9%) |
| Sep 2017 | - | $567.31M(+3.1%) |
| Jun 2017 | - | $550.37M(+4.0%) |
| Mar 2017 | - | $529.13M(+1.5%) |
| Dec 2016 | $521.34M(-29.5%) | $521.34M(+3.3%) |
| Sep 2016 | - | $504.79M(-13.2%) |
| Jun 2016 | - | $581.61M(-12.0%) |
| Mar 2016 | - | $660.95M(-10.6%) |
| Dec 2015 | $739.40M(-6.8%) | $739.40M(-8.4%) |
| Sep 2015 | - | $806.83M(+5.1%) |
| Jun 2015 | - | $767.67M(-2.3%) |
| Mar 2015 | - | $785.71M(-0.9%) |
| Dec 2014 | $792.93M(+61.9%) | $792.93M(-2.1%) |
| Sep 2014 | - | $810.11M(+56.3%) |
| Jun 2014 | - | $518.32M(-0.9%) |
| Mar 2014 | - | $522.86M(+6.8%) |
| Dec 2013 | $489.69M(-28.3%) | $489.69M(+13.4%) |
| Sep 2013 | - | $431.95M(+11.6%) |
| Jun 2013 | - | $387.19M(-47.1%) |
| Mar 2013 | - | $731.58M(+7.1%) |
| Dec 2012 | $683.20M(+49.8%) | $683.20M(+70.8%) |
| Sep 2012 | - | $400.00M(0.0%) |
| Jun 2012 | - | $400.00M(0.0%) |
| Mar 2012 | - | $400.00M(-12.3%) |
| Dec 2011 | $455.95M(+14.0%) | $455.95M(+14.0%) |
| Sep 2011 | - | $400.00M(0.0%) |
| Jun 2011 | - | $400.00M(0.0%) |
| Mar 2011 | - | $400.00M(0.0%) |
| Dec 2010 | $400.00M(+228.5%) | $400.00M(-17.9%) |
| Sep 2010 | - | $487.23M(+463.9%) |
| Jun 2010 | - | $86.41M(-31.0%) |
| Mar 2010 | - | $125.32M(+2.9%) |
| Dec 2009 | $121.77M(-57.6%) | $121.77M(-53.7%) |
| Sep 2009 | - | $262.84M(+82.5%) |
| Jun 2009 | - | $144.00M(-49.9%) |
| Mar 2009 | - | $287.50M(0.0%) |
| Dec 2008 | $287.50M | $287.50M(0.0%) |
| Sep 2008 | - | $287.50M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | - | $287.50M(0.0%) |
| Mar 2008 | - | $287.50M(+1337.7%) |
| Mar 2007 | - | $20.00M(0.0%) |
| Dec 2006 | $20.00M(-88.9%) | $20.00M(-66.5%) |
| Sep 2006 | - | $59.65M(-66.9%) |
| Jun 2006 | - | $180.09M(-0.0%) |
| Mar 2006 | - | $180.10M(0.0%) |
| Dec 2005 | $180.10M(-46.2%) | $180.10M(-38.9%) |
| Sep 2005 | - | $294.55M(-12.1%) |
| Jun 2005 | - | $335.00M(0.0%) |
| Mar 2005 | - | $335.00M(0.0%) |
| Dec 2004 | $335.00M(+0.5%) | $335.00M(+6.3%) |
| Sep 2004 | - | $315.00M(-0.9%) |
| Jun 2004 | - | $317.93M(+0.9%) |
| Mar 2004 | - | $315.00M(-5.5%) |
| Dec 2003 | $333.46M(+2.3%) | $333.46M(-2.1%) |
| Sep 2003 | - | $340.50M(+1.0%) |
| Jun 2003 | - | $337.29M(+2.7%) |
| Mar 2003 | - | $328.52M(+0.8%) |
| Dec 2002 | $325.94M(+0.9%) | $325.94M(+1.4%) |
| Sep 2002 | - | $321.31M(-0.1%) |
| Jun 2002 | - | $321.73M(-0.2%) |
| Mar 2002 | - | $322.33M(-0.2%) |
| Dec 2001 | $323.03M(-9.6%) | $323.03M(-8.8%) |
| Sep 2001 | - | $354.19M(+2.2%) |
| Jun 2001 | - | $346.63M(-0.1%) |
| Mar 2001 | - | $346.97M(-2.9%) |
| Dec 2000 | $357.27M(+7512.8%) | $357.27M(+2.6%) |
| Sep 2000 | - | $348.12M(+94.9%) |
| Jun 2000 | - | $178.62M(-0.3%) |
| Mar 2000 | - | $179.16M(+3717.5%) |
| Dec 1999 | $4.69M(-33.0%) | $4.69M(-11.5%) |
| Sep 1999 | - | $5.30M(-8.6%) |
| Jun 1999 | - | $5.80M(-9.4%) |
| Mar 1999 | - | $6.40M(-8.6%) |
| Dec 1998 | $7.00M(+18.6%) | $7.00M(-7.9%) |
| Sep 1998 | - | $7.60M(+10.1%) |
| Jun 1998 | - | $6.90M(+11.3%) |
| Mar 1998 | - | $6.20M(+5.1%) |
| Dec 1997 | $5.90M(+5.4%) | $5.90M(+7.3%) |
| Sep 1997 | - | $5.50M(+1.9%) |
| Jun 1997 | - | $5.40M(+1.9%) |
| Mar 1997 | - | $5.30M(-5.4%) |
| Dec 1996 | $5.60M(+14.3%) | $5.60M(+27.3%) |
| Sep 1996 | - | $4.40M(-4.3%) |
| Jun 1996 | - | $4.60M(+4.5%) |
| Mar 1996 | - | $4.40M(-10.2%) |
| Dec 1995 | $4.90M(+4.3%) | $4.90M(0.0%) |
| Sep 1995 | - | $4.90M(-3.9%) |
| Jun 1995 | - | $5.10M(+4.1%) |
| Mar 1995 | - | $4.90M(+4.3%) |
| Dec 1994 | $4.70M(+11.9%) | $4.70M(0.0%) |
| Sep 1994 | - | $4.70M(+6.8%) |
| Jun 1994 | - | $4.40M(+12.8%) |
| Mar 1994 | - | $3.90M(-7.1%) |
| Dec 1993 | $4.20M(+27.3%) | $4.20M(+5.0%) |
| Sep 1993 | - | $4.00M(+2.6%) |
| Jun 1993 | - | $3.90M(+14.7%) |
| Mar 1993 | - | $3.40M(+3.0%) |
| Dec 1992 | $3.30M(+57.1%) | $3.30M(0.0%) |
| Sep 1992 | - | $3.30M(+13.8%) |
| Jun 1992 | - | $2.90M(+26.1%) |
| Mar 1992 | - | $2.30M(+9.5%) |
| Dec 1991 | $2.10M(-12.5%) | $2.10M(-12.5%) |
| Sep 1991 | - | $2.40M(-4.0%) |
| Jun 1991 | - | $2.50M(+4.2%) |
| Dec 1990 | $2.40M | $2.40M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual long term debt?
- What is the all time high annual long term debt for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual long term debt year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly long term debt?
- What is the all time high quarterly long term debt for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly long term debt year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual long term debt?
The current annual long term debt of VRTX is $1.66B
What is the all time high annual long term debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual long term debt is $1.66B
What is Vertex Pharmaceuticals Incorporated annual long term debt year-on-year change?
Over the past year, VRTX annual long term debt has changed by +$932.50M (+128.67%)
What is Vertex Pharmaceuticals Incorporated quarterly long term debt?
The current quarterly long term debt of VRTX is $1.65B
What is the all time high quarterly long term debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly long term debt is $1.70B
What is Vertex Pharmaceuticals Incorporated quarterly long term debt year-on-year change?
Over the past year, VRTX quarterly long term debt has changed by +$927.80M (+128.63%)